Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Plants (Basel, Switzerland)|February 13, 2025
Fatty Acid ABCG Transporter GhSTR1 Mediates Resistance to Verticillium dahliae and Fusarium oxysporum in CottonGuanfu Cheng, Xiuqing Li, W G Dilantha Fernando, et al.
Leukemia & Lymphoma|April 28, 2022
CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemiaQiaoqiao Li, Chunyan Liang, Xintong Xu, et al.
ACS Applied Materials & Interfaces|September 25, 2018
Bilayer Tubular Micromotors for Simultaneous Environmental Monitoring and RemediationChunyan Liang, Chen Zhan, Fanyu Zeng, et al.
Journal of Cancer|January 18, 2020
Consistency Analysis of Programmed Death-Ligand 1 Expression between Primary and Metastatic Non-Small Cell Lung Cancer: A Retrospective StudyLuqiao Luo, Xinlan Luo, Wendan Chen, et al.
ACS Applied Materials & Interfaces|June 28, 2021
Cost-Effective, High-Yield Production of Biotemplated Catalytic Tubular Micromotors as Self-Propelled Microcleaners for Water TreatmentLing Chen, Hao Yuan, Shuqin Chen, et al.
Frontiers in Molecular Biosciences|July 11, 2026
Integrative analysis of cuproptosis in kidney ischemia-reperfusion injury: biomarker discovery and diagnostic model constructionChunyan Liang, Lixin Fu, Manling Xie, et al.
Toxicology and Applied Pharmacology|December 17, 2024
Neuregulin 1 improved gastric motility and reduced gastric inflammation by activating the α7nAChR through the cholinergic anti-inflammatory pathway in diabetic ratsWeigang Cui, Yuqi Ma, Libin Zhang, et al.
Frontiers in Immunology|June 4, 2026
Integrated transcriptomic profiling of programmed cell death patterns unveils macrophage-hepatocyte crosstalk via THBS1-CD47 axis in hepatic ischemia-reperfusion injuryManling Xie, Changquan Zhang, Lirong Zhu, et al.
American Journal of Translational Research|July 19, 2018
Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responsesZining Jin, Lu Xu, Lei Zhang, et al.
Oncology Letters|November 4, 2014
Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancerShiyong Wang, Hui Zhang, Chang Liu, et al.
Pageof 4